Evidence map›Paper›PMID 35662988›Full record

ArticleWorld journal of clinical oncology2022

How to improve metastatic pancreatic ductal adenocarcinoma patients' selection: Between clinical trials and the real-world.

Andrea Pretta, Dario Spanu, Stefano Mariani, Nicole Liscia, Pina Ziranu, Valeria Pusceddu, Marco Puzzoni, Elena Massa, Mario Scartozzi, Eleonora Lai

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of clinical oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Andrea PrettaMedical Oncology Unit, University Hospital and University of Cagliari, Monserrato 09042, Cagliari, Italy.
Dario SpanuMedical Oncology Unit, University Hospital and University of Cagliari, Monserrato 09042, Cagliari, Italy.
Stefano MarianiMedical Oncology Unit, University Hospital and University of Cagliari, Monserrato 09042, Cagliari, Italy.
Nicole LisciaDepartment of Oncology, IRCCS San Raffaele Scientific Institute Hospital, Vita-Salute San Raffaele University, Milano 20121, Italy.
Pina ZiranuMedical Oncology Unit, University Hospital and University of Cagliari, Monserrato 09042, Cagliari, Italy.
Valeria PuscedduMedical Oncology Unit, University Hospital and University of Cagliari, Monserrato 09042, Cagliari, Italy.
Marco PuzzoniMedical Oncology Unit, University Hospital and University of Cagliari, Monserrato 09042, Cagliari, Italy.
Elena MassaMedical Oncology Unit, University Hospital and University of Cagliari, Monserrato 09042, Cagliari, Italy.
Mario ScartozziMedical Oncology Unit, University Hospital and University of Cagliari, Monserrato 09042, Cagliari, Italy. marioscartozzi@gmail.com.
Eleonora LaiMedical Oncology Unit, University Hospital and University of Cagliari, Monserrato 09042, Cagliari, Italy.
Jackson and Tull (United States) · USCreative Research Enterprises (United States) · USIstituti di Ricovero e Cura a Carattere Scientifico · ITUniversity of Cagliari · ITVita-Salute San Raffaele University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As underlined in the minireview by Blomstrand

Indexed as

BiomarkersMetastatic pancreatic ductal adenocarcinomaMolecular selectionPalliative chemotherapyReal-world dataSecond-line treatment

Identifiers

PMID35662988
PMCPMC9153079
OpenAlexW4281389387

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.